Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock Movers: Monte Dei Paschi, Tate & Lyle, Zealand Pharma
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved…
After IAP exit, Hyderabad paediatrician Sivaranjani Santosh alleges pharma influence, seeks probe into ORSL promotion
Hyderabad-based paediatrician Dr Sivaranjani Santosh has said that her resignation from the Indian Academy of Paediatrics (IAP), which she submitted nearly two months ago, has now been formally accepted by the organisation. In a post on social…
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea, June 7, 2026 /CNW/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized…
Lupin partners with Spanish pharma company Laboratorios ERN on respiratory drug, for Spain
Lupin Limited is partnering with Spanish pharma company Laboratorios ERN SA to launch its fixed dose combination Luforbec (beclometasone/formoterol), in Spain. The drug, administered through a pressurized metered dose inhaler (pMDI), is used to…
Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech
After years of lagging the market, healthcare may be taking on a new role in investor portfolios. Speaking on CNBC, Mizuho healthcare strategist Jared Holz reframed the sector, arguing that years of underperformance have turned drug stocks from a…
Royalty Pharma PLC $RPRX Stock Position Increased by Brandywine Global Investment Management LLC
Brandywine Global Investment Management LLC raised its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm…
Capital International Ltd. CA Sells 4,811 Shares of Ascendis Pharma A/S $ASND
Capital International Ltd. CA trimmed its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 22.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 16,861 shares of the biotechnology…
Capital International Inc. CA Acquires 58,030 Shares of Royalty Pharma PLC $RPRX
Capital International Inc. CA raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 8.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
Stock Markets Tumble: West Asia Tensions, Oil Prices, and Global Sell-Off Impact Indian Equities
Indian stock markets, including the Sensex and Nifty, plunged in early trade amidst a sharp global equities decline, a fresh surge in crude oil prices due to escalating West Asia tensions, and a significant unwinding of the global AI-led rally.
New data may cast doubt on competitiveness of Boehringer's obesity drug
New data on Boehringer Ingelheim's obesity candidate suggest the drug may be helpful in cutting liver fat, but it's not clear how competitive the treatment would be since it appears less efficacious and less tolerable than drugs on the market. In a…
Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On
Aclaris Therapeutics Inc. (NASDAQ: ACRS) is one of the top penny stocks to buy in investors' stock portfolio. On May 8, Stifel reiterated a Hold rating on Aclaris Therapeutics Inc. (NASDAQ:ACRS) and increased the price target to $4 from $3. The…
Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP-1 dual agonist, from baseline. …
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on Valueinvestorsclub.com by Bohr. In this article, we will summarize the bulls' thesis on VIR. Vir Biotechnology, Inc.'s share was trading at $9.19 as of May…
Sensex, Nifty trim losses in afternoon trade, metals, realty and auto stocks drag
Equity benchmark indices recovered from the day's low but continued to trade in negative territory during afternoon trade on Monday amid broad-based selling pressure across sectors. The BSE Sensex traded 440.21 points or 0.59 per cent lower at…
Receive a Daily briefing on Pharma Industry News
Get Started